Mark Katakowski

Mark Katakowski received a B.S. in Physics and a Ph.D. in Medical Physics from Oakland University. He has over 15 years experience investigating bone mesenchymal stem cell (MSC) therapies for neurological disease, and an extensive scientific publication record. Dr. Katakowski was first to demonstrate that microRNA functions as an intercellular communication molecule between brain tumor cells. This work led to his finding that bone marrow MSCs communicate with the nervous system via blood-born exosomes. Dr. Katakowski's hypothesis that bone marrow cell degradation contributes to aging and age-related disease is the founding principle of Forever Labs.